Laquinimod Study in Active Crohn's Disease

Study Title
Laquinimod Phase IIa Study in Active Crohn's Disease
Teva Identifier
CD-LAQ-201
ClinicalTrials.gov Identifier
NCT00737932
Study Status
Completed
Trial Condition(s)
Crohn's Disease
Interventions
Drug: Laquinimod | Other: placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 75 Years
Trial Duration
05/01/2010 - 12/01/2011
Phase
Phase 2

Study Type

Interventional